<bill session="116" type="h" number="478" updated="2022-11-01T13:49:17Z">
  <state datetime="2019-01-10">REFERRED</state>
  <status>
    <introduced datetime="2019-01-10"/>
  </status>
  <introduced datetime="2019-01-10"/>
  <titles>
    <title type="display">Safe and Affordable Drugs from Canada Act of 2019</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to allow for the personal importation of safe and affordable drugs from approved pharmacies in Canada.</title>
    <title type="short" as="introduced">Safe and Affordable Drugs from Canada Act of 2019</title>
  </titles>
  <sponsor bioguide_id="P000597"/>
  <cosponsors>
    <cosponsor bioguide_id="C001055" joined="2019-01-30"/>
    <cosponsor bioguide_id="C001068" joined="2019-01-30"/>
    <cosponsor bioguide_id="C001119" joined="2019-03-26"/>
    <cosponsor bioguide_id="D000399" joined="2019-01-30"/>
    <cosponsor bioguide_id="G000559" joined="2019-01-30"/>
    <cosponsor bioguide_id="G000592" joined="2019-01-16"/>
    <cosponsor bioguide_id="H001056" joined="2019-01-10"/>
    <cosponsor bioguide_id="J000295" joined="2019-10-23"/>
    <cosponsor bioguide_id="K000389" joined="2019-05-10"/>
    <cosponsor bioguide_id="L000563" joined="2019-01-30"/>
    <cosponsor bioguide_id="R000613" joined="2019-03-26"/>
    <cosponsor bioguide_id="R000577" joined="2019-05-10"/>
    <cosponsor bioguide_id="S001208" joined="2019-10-17"/>
    <cosponsor bioguide_id="T000165" joined="2020-08-11"/>
    <cosponsor bioguide_id="W000800" joined="2019-02-13"/>
  </cosponsors>
  <actions>
    <action datetime="2019-01-10">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-01-10" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-01-25">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="61" relation="identical"/>
    <bill session="116" type="s" number="3384" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Canada"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government information and archives"/>
    <term name="Prescription drugs"/>
    <term name="Trade restrictions"/>
  </subjects>
  <amendments/>
  <summary date="2020-03-31T18:43:51Z" status="Introduced in House">Safe and Affordable Drugs from Canada Act of 2019 

This bill requires the Food and Drug Administration (FDA)to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug

 is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA. Under the bill, certain drugs may not be imported, including controlled substances and biological products.

The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.</summary>
</bill>
